Inventor · disambiguated record
Naoko Namiki
Also filed as: NAMIKI NAOKO
5 granted patents·2 pending applications·16 citations·filing 2018–2023
75Inventor score
Files withTEIJIN PHARMA LTD7
Top patents by PatentIndex Score
7 records- 0191US10894829B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2020·Granted Jan 19, 2021·3 cites·17 claims
- 0291US10556950B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2018·Granted Feb 11, 2020·9 cites·36 claims
- 0388US11739143B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2020·Granted Aug 29, 2023·2 cites·16 claims
- 0477US12227563B2Anti-IGF-I receptor humanized antibodyTEIJIN PHARMA LTD·Filed 2019·Granted Feb 18, 2025·1 cites·6 claims
- 0576US11629194B2Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodiesTEIJIN PHARMA LTD·Filed 2018·Granted Apr 18, 2023·1 cites·44 claims
- 0670US2023192868A1Anti-igf-i receptor antibodyTEIJIN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0756US2025263489A1Anti-igf-1 receptor humanized antibodyTEIJIN PHARMA LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naoko Namiki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →